Abstract
Leprosy is an infectious and contagious chronic disease, affecting mainly the skin and the peripheral nerves. It may cause disability due to the peripheral neurological damage, as well as from the ocular disease. Although less frequent, the latter may be severe and irreversible.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agrawal A, Pandit L, Dalal M et al (2005) Neurological manifestations of Hansen’s disease and their management. Clin Neurol Neurosurg 107:445–454
Boratto LM, Oréfice F, Werner LP et al (1998) Dacryocystographic examination does not identify early seventh nerve failure in leprosy patients. Indian J Lepr 70:287–289
Ministério da Saúde do Brasil (2002) Secretaria de PolÃticas de Saúde – Departamento de Atenção Básica. Guia para o Controle da HansenÃase. BrasÃlia, 89 p
Ministério da Saúde do Brasil (2003) Secretaria de PolÃticas de Saúde – Departamento de Atenção Básica. Manual de Condutas para Complicações Oculares. BrasÃlia, 59 p
Britton WJ (1998) The management of leprosy reversal reactions. Lepr Rev 69:225–234
Britton WJ, Lockwood DN (2004) Leprosy. Lancet 363:1209–1219
Campos WB, Oréfice F, Rodrigues CA et al (1996) Mycobacterium leprae scleritis in a patient after many years of dapsone therapy. Rev Bras Oftalmol 55:167–174
Campos WB, Oréfice F, Sucena MA et al (1998) Conjunctival biopsy in patients with leprosy. Indian J Lepr 70:291–294
Campos WR, Oréfice F, Sucena MA et al (1998) Bilateral iridocyclitis caused by Mycobacterium leprae diagnosed through paracentesis. Indian J Lepr 70:27–31
Campos WB, Rodrigues CA, Oréfice F et al (1995) M. leprae eradication by multidrug therapy and superior tarsal conjunctival scrape. Rev Bras Oftalmol 54:267–274
Campos WR, Rodrigues CA, Oréfice F et al (1998) Identification of M.leprae in conjunctiva of leprosy patients using the superior tarsal conjunctiva scrape technique. Indian J Lepr 70:397–403
Campos WR, Rodrigues CAF, Oréfice F (2005) HansenÃanse. In: Oréfice F (ed) UveÃte clÃnica e cirúrgica. Cultura Médica, Rio de Janeiro, pp 419–448
Daniel E, Koshy S (2002) Intraocular lens implantation in leprosy. Int J Lepr Other Mycobact Dis 70:9–15
Daniel E, Koshy S, Rao GS et al (2002) Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort. Br J Ophthalmol 86:1336–1340
Daniel E, Sundar Rao PS (2007) Evolution of vision reducing cataract in skin smear positive lepromatous patients: does it have an inflammatory basis? Br J Ophthalmol 91:1011–1013
Frota E, Oréfice F (1989) Intraocular lens in patients bearing Hansen’s disease. Rev Bras Oftalmol 48:205–207
Hogeweg M, Keunen JE (2005) Prevention of blindness in leprosy and the role of the Vision 2020 Programme. Eye 19:1099–1105
Katoch VM (2002) Advances in the diagnosis and treatment of leprosy. Expert Rev Mol Med 4:1–14
Mendes AG, Oréfice F, Campos WB et al (1996) Comparison between the Semmes-Weinstein and the Cochet & Bonnet esthesiometers in the evaluation of corneal sensitivity. Rev Bras Oftalmol 55:41–51
Monteiro LG, Campos WR, Oréfice F et al (1998) Study of ocular changes in leprosy patients. Indian J Lepr 70:197–202
Murthy PK (2004) Clinical manifestations, diagnosis and classification of leprosy. J Indian Med Assoc 102:678–679
Mvogo CE, Bella-Hiag AL, Ellong A et al (2001) Ocular complications of leprosy in Cameroon. Acta Ophthalmol Scand 79:31–33
Oréfice F, Boratto LM (1998) Clinical ocular study in leprosy patients at a sanitary dermatological hospital in Brazil. Indian J Lepr 70:189–195
Oréfice F, Miranda D, Boratto LM (1998) Presence of M. leprae in the conjunctiva, vitreous body and retina of a patient having lepromatous leprosy. Indian J Lepr 70:97–102
Samanta SK, Das D (2007) Recent advances in ocular leprosy. Indian J Lepr 79:135–150
Scollard DM, Adams LB, Gillis TP et al (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19:338–381
Thompson KJ, Allardice GM, Babu GR et al (2006) Patterns of ocular morbidity and blindness in leprosy–a three centre study in Eastern India. Lepr Rev 77:130–140
Waddell KM, Saunderson PR (1995) Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. Br J Ophthalmol 79:250–256
Walker SL, Waters MF, Lockwood DN (2007) The role of thalidomide in the management of erythema nodosum leprosum. Lepr Rev 78:197–215
World Health Organization (1998) Expert committee on leprosy, 7th Report: 1–43
World Health Organization (2007) Weekly epidemiological record 82:225–232. Available at http://www.who.int/wer
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
1 Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Case Report 57
Leprosy (PPT 4098 kb)
Rights and permissions
Copyright information
© 2016 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Oréfice, F., Campos, W.R., Cordeiro, C.A. (2016). Leprosy. In: Zierhut, M., Pavesio, C., Ohno, S., Orefice, F., Rao, N. (eds) Intraocular Inflammation. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-75387-2_102
Download citation
DOI: https://doi.org/10.1007/978-3-540-75387-2_102
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-75385-8
Online ISBN: 978-3-540-75387-2
eBook Packages: MedicineMedicine (R0)